Full Text View
Tabular View
No Study Results Posted
Related Studies
Weight Gain in CF
This study has been completed.
Study NCT00006169   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: August 8, 2000   Last Updated: June 23, 2005   History of Changes

August 8, 2000
June 23, 2005
June 1996
 
 
 
Complete list of historical versions of study NCT00006169 on ClinicalTrials.gov Archive Site
 
 
 
Weight Gain in CF
Behavioral Treatment of Weight Gain in CF

The current study examines the efficacy of two treatments to help children with cystic fibrosis (CF) meet their dietary calorie requirements of 120% to 150% of the recommended daily allowance of energy and the effect of these treatments on weight gain and maintenance. One treatment provides children with CF and their parents nutrition education about the best foods for meeting their dietary needs. The second treatment gives children with CF and their families similar nutritional information plus behavioral parenting methods for motivating children to eat the recommended foods. Children with CF and their families are seen weekly for 7 treatment sessions across 9 weeks for the active phase of treatment. Families are then followed for 2 years after treatment in order to better understand how long the treatments are effective and to determine the health benefits of better nutrition status and weight gain.

 
Phase III
Interventional
Prevention
Cystic Fibrosis
Behavioral: Behavioral Treatment
 
Stark LJ, Quittner AL, Powers SW, Opipari-Arrigan L, Bean JA, Duggan C, Stallings VA. Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2009 Oct;163(10):915-21.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
November 1999
 

Inclusion Criteria:

  • Weight percentile for age or height below 40th for age and sex
  • Pancreatic insufficiency

Exclusion Criteria:

  • Developmental delays
  • Pseudomonas cepacia
  • Supplemental enteral or parenteral nutrition
Both
4 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00006169
 
Stark, 50092
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 
Principal Investigator: Lori Stark Children's Hospital Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
July 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP